{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T15:41:46Z","timestamp":1791906106102,"version":"4.3.4"},"reference-count":28,"publisher":"Public Library of Science (PLoS)","issue":"3","license":[{"start":{"date-parts":[[2012,3,1]],"date-time":"2012-03-01T00:00:00Z","timestamp":1330560000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0031801","type":"journal-article","created":{"date-parts":[[2012,3,2]],"date-time":"2012-03-02T15:42:10Z","timestamp":1330702930000},"page":"e31801","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":405,"title":["Triazole Fungicides Can Induce Cross-Resistance to Medical Triazoles in Aspergillus fumigatus"],"prefix":"10.1371","volume":"7","author":[{"given":"Eveline","family":"Snelders","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simone M. T.","family":"Camps","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Karawajczyk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gijs","family":"Schaftenaar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gert H. J.","family":"Kema","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henrich A.","family":"van der Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Corn\u00e9 H.","family":"Klaassen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Willem J. G.","family":"Melchers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul E.","family":"Verweij","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2012,3,1]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1086\/524669","article-title":"Voriconazole therapeutic drug monitoring in patients with invasive mycoses improves efficacy and safety outcomes.","volume":"46","author":"A Pascual","year":"2008","journal-title":"Clin Infect Dis"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"3564","DOI":"10.1128\/AAC.01544-10","article-title":"Failure of posaconazole therapy in a renal transplant patient with invasive aspergillosis due to <italic>Aspergillus fumigatus<\/italic> with attenuated susceptibility to posaconazole.","volume":"55","author":"S Kuipers","year":"2011","journal-title":"Antimicrob Agents Chemother"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"4758","DOI":"10.1128\/AAC.00606-10","article-title":"Impact of cyp51A mutations on the pharmacokinetic and pharmacodynamic properties of voriconazole in a murine model of disseminated aspergillosis.","volume":"54","author":"E Mavridou","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1056\/NEJMc061720","article-title":"Multiple-triazole-resistant aspergillosis.","volume":"356","author":"PE Verweij","year":"2007","journal-title":"N Engl J Med"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.3201\/eid1507.090043","article-title":"Frequency and evolution of azole resistance in <italic>Aspergillus fumigatus<\/italic> associated with treatment failure.","volume":"15","author":"SJ Howard","year":"2009","journal-title":"Emerging Infectious Diseases"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"e219","DOI":"10.1371\/journal.pmed.0050219","article-title":"Emergence of azole resistance in <italic>Aspergillus fumigatus<\/italic> and spread of a single resistance mechanism.","volume":"5","author":"E Snelders","year":"2008","journal-title":"PLoS Med"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1016\/S1473-3099(09)70265-8","article-title":"Azole resistance in <italic>Aspergillus fumigatus<\/italic>: a side-effect of environmental fungicide use?","volume":"9","author":"PE Verweij","year":"2009","journal-title":"Lancet Infect Dis"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"1846","DOI":"10.3201\/eid1710.110226","article-title":"Clinical implications of azole resistance in <italic>Aspergillus fumigatus<\/italic>, the Netherlands, 2007\u20132009.","volume":"17","author":"JWM Van der Linden","year":"2011","journal-title":"Emerg Infect Dis"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1128\/AAC.01092-06","article-title":"A new <italic>Aspergillus fumigatus<\/italic> resistance mechanism conferring in vitro cross-resistance to azole antifungals involves a combination of cyp51A alterations.","volume":"51","author":"E Mellado","year":"2007","journal-title":"Antimicrob Agents Chemother"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"4053","DOI":"10.1128\/AEM.00231-09","article-title":"Possible environmental origin of resistance of <italic>Aspergillus fumigatus<\/italic> to medical triazoles.","volume":"75","author":"E Snelders","year":"2009","journal-title":"Appl Environ Microbiol"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1086\/597465","article-title":"Azole-resistant central nervous system aspergillosis.","volume":"48","author":"JWM Van Der Linden","year":"2009","journal-title":"Clin Infect Dis"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1111\/j.1364-3703.2007.00464.x","article-title":"Evolution of the CYP51 gene in <italic>Mycosphaerella graminicola<\/italic>: evidence for intragenic recombination and selective replacement.","volume":"9","author":"PC Brunner","year":"2008","journal-title":"Mol Plant Pathol"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"4545","DOI":"10.1128\/AAC.00692-10","article-title":"Environmental study of azole-resistant <italic>Aspergillus fumigatus<\/italic> and other aspergilli in Austria, Denmark, and Spain.","volume":"54","author":"KL Mortensen","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"4465","DOI":"10.1128\/AAC.00185-11","article-title":"Azole resistance in <italic>Aspergillus fumigatus<\/italic> isolates from the ARTEMIS global surveillance is primarily due to the TR\/L98H mutation in the cyp51A gene.","volume":"55","author":"SR Lockhart","year":"2011","journal-title":"Antimicrob Agents Chemother"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1093\/jac\/dkq450","article-title":"Low prevalence of resistance to azoles in <italic>Aspergillus fumigatus<\/italic> in a French cohort of patients treated for haematological malignancies.","volume":"66","author":"A Alanio","year":"2011","journal-title":"J Antimicrob Chemother"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1093\/jac\/dkr008","article-title":"Comment on: Low prevalence of resistance to azoles in <italic>Aspergillus fumigatus<\/italic> in a French cohort of patients treated for haematological malignancies.","volume":"66","author":"PE Verweij","year":"2011","journal-title":"J Antimicrob Chemother"},{"key":"ref17","article-title":"National Committee for Clinical Laboratory Standards. Reference method for broth dilution antifungal susceptibility testing of filamentous fungi. Approved standard M38-A","year":"2002"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"2483","DOI":"10.1128\/AAC.01651-10","article-title":"An improved model of the <italic>Aspergillus fumigatus<\/italic> CYP51A protein.","volume":"55","author":"MG Fraczek","year":"2011","journal-title":"Antimicrob Agents Chemother"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1002\/(SICI)1097-0134(19991101)37:2<228::AID-PROT8>3.0.CO;2-8","article-title":"Evaluation of the FLEXX incremental construction algorithm for protein-ligand docking.","volume":"37","author":"B Kramer","year":"1999","journal-title":"Proteins"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1006\/jmbi.1996.0477","article-title":"A fast flexible docking method using an incremental construction algorithm.","volume":"261","author":"M Rarey","year":"1996","journal-title":"J Mol Biol"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"3068","DOI":"10.1073\/pnas.061562898","article-title":"Crystal structure of cytochrome P450 14alpha -sterol demethylase (CYP51) from <italic>Mycobacterium tuberculosis<\/italic> in complex with azole inhibitors.","volume":"98","author":"LM Podust","year":"2001","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1016\/j.jmb.2010.01.075","article-title":"Structural basis of human CYP51 inhibition by antifungal azoles.","volume":"397","author":"N Strushkevich","year":"2010","journal-title":"J Mol Biol"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"4112","DOI":"10.1128\/JCM.43.8.4112-4120.2005","article-title":"Use of a novel panel of nine short tandem repeats for exact and high-resolution fingerprinting of <italic>Aspergillus fumigatus<\/italic> isolates.","volume":"43","author":"HA de Valk","year":"2005","journal-title":"J Clin Microbiol"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1037\/1082-989X.1.4.331","article-title":"Computing contrasts, effect sizes, and countermills on other people&apos;s published data: general procedures for research consumers.","volume":"1","author":"RL Rosnow","year":"1996","journal-title":"Psychol Meth"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1080\/13693780802545600","article-title":"Multiple-azole-resistant <italic>Aspergillus fumigatus<\/italic> osteomyelitis in a patient with chronic granulomatous disease successfully treated with long-term oral posaconazole and surgery.","volume":"47","author":"CJ Hodiamont","year":"2009","journal-title":"Med Mycol"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1126\/science.326.5957.1173","article-title":"Infectious diseases. Farm fungicides linked to resistance in a human pathogen.","volume":"326","author":"M Enserink","year":"2009","journal-title":"Science"},{"key":"ref27","article-title":"A new resistance mechanism from environmental origin conferring to voriconazole resistance has emerged in clinical <italic>Aspergillus fumigatus<\/italic> isolates in the Netherlands.","author":"PE Verweij","year":"2010"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1093\/cid\/cir179","article-title":"High-frequency triazole resistance found in nonculturable <italic>Aspergillus fumigatus<\/italic> from lungs of patients with chronic fungal disease.","volume":"52","author":"DW Denning","year":"2011","journal-title":"Clin Infect Dis"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0031801","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,9]],"date-time":"2020-05-09T02:41:38Z","timestamp":1588992098000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0031801"}},"subtitle":[],"editor":[{"given":"Marta","family":"Feldmesser","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2012,3,1]]},"references-count":28,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2012,3,1]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0031801","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,3,1]]}}}